Genetic testing for hereditary arrhythmia and cardiomyopathy in an area with known founder effects on local genetic variants ...

As Baylor Genetics celebrates a decade of leadership at the forefront of genetic testing, it is set to exhibit its latest scientific studies in genetic testing at the 2025 ACMG Annual Clinical ...

TeleRare Health™ launched a partnership today with a leading community health system in Maryland, with a focus on expanding patient access to genetic testing, diagnosis, and knowledgeable care for ...

The latest research led from Manchester could revolutionize the diagnosis of Perrault syndrome, a rare genetic condition that ...

It's estimated 65,000 New Zealand are already living with the eye disease glaucoma, but are totally unaware. Early stage glaucoma has no symptoms until damage has already been caused. But if caught ...

Rise in prevalence of cancer and the necessary attention in early diagnosis and treatment to boost market demand, States Fact.MRRockville, MD, ...

Qlucore introduces the first CE-marked diagnostic test for pediatric leukemia according to the mandatory regulatory framework in Europe (IVDR). Now available for delivery and clinical use, Qlucore ...

Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide, with approximately 20% of patients ...

Dr. Park shares the three biggest takeaways, in his opinion, to have come out of the ASCO GU Symposium, highlighting studies ...

The global DNA diagnostics market is on an impressive growth trajectory, with sales projected to reach USD 27,094.2 million in 2024, and further expanding to USD 57,420.1 million by 2034. This surge ...

Researchers at the University of Washington and Seattle Children's found that using exclusion-based criteria to refer infants for genetic testing in the NICU led to more diagnoses and at earlier ages.